Clinical Trials Directory

Trials / Unknown

UnknownNCT02312674

Prevention of Cancer-associated Malnutrition Through Oral Nutritional Supplements

Prevention of Malnutrition Through Oral Nutritional Supplements in Cancer Patients Receiving Palliative Therapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University of Hohenheim · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of the randomized controlled study is to determine effects of an adjusted amount of oral nutritional supplements on the quality of life, the nutritional status, side effects, and response to therapy, in patients with pancreatic and hepatocellular carcinoma receiving palliative therapy.

Detailed description

Cancer is often associated with malnutrition and weight loss. The occurence of malnutrition during the course of the disease depends on the type, extent, and therapy of the tumor. Pancreatic cancer patients and patients with hepatocellular carcinoma are particularly at risk of developing a pronounced weight loss. Cancer-related malnutrition has negative impact on the response to therapy, survival, quality of life, and the infection rate of patients, resulting in prolonged hospital stays and higher costs for health care. Maintaining or optimizing the quality of life in patients receiving palliative therapy has priority. Since a poor nutritional status affects the quality of life, patients might benefit from the use of an adjusted amount of oral nutritional supplements. To determine the effects of oral nutritional supplements, a controlled randomized study will be conducted.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOral nutritional supplementBeginning with the start of palliative therapy, depending on the nutritional status, one, two, or three cans per day are ingested during a period of three months.

Timeline

Start date
2015-01-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2014-12-09
Last updated
2014-12-09

Source: ClinicalTrials.gov record NCT02312674. Inclusion in this directory is not an endorsement.